Literature DB >> 15539020

[Effect of integrated traditional Chinese and Western medicine therapy on progression of acute renal failure in patients with chronic renal insufficiency: a short-term clinical study].

Peng Fu1, Guang Yu, Xue-Qiang Huang, Jing Xu, Xiao-Bin Mei, Hao Wu, Wei-Jie Yuan.   

Abstract

OBJECTIVE: To evaluate the effect of integrated traditional Chinese and Western medicine therapy on the progression of acute renal failure in patients with chronic renal insufficiency.
METHODS: Thirty-two patients with chronic renal insufficiency developed acute renal failure recently were treated with Chinese herbs and western drugs intravenously and clysterizing of Chinese herbs liquid for 30 minutes, and the treatment course was 14 days. Assessment of liver and renal function, blood routine, electrolytes and endogenous creatinine clearance rate (Ccr) was performed before and 2 weeks after the treatment.
RESULTS: The levels of hemoglobin (HB), white blood cell count (WBC) and serum electrolytes showed no significant changes after the treatment. The levels of blood urea nitrogen (BUN) and serum creatinine (SCr) decreased, while the level of Ccr increased significantly (P<0.05) after the treatment. The total effective rate was 65.6%.
CONCLUSION: The integrated traditional Chinese and Western medicine therapy can effectively delay the deterioration of renal function in patients with chronic renal insufficiency accompanied by acute renal failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539020     DOI: 10.3736/jcim20040608

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  2 in total

1.  Protection of Chinese herbs against adenine-induced chronic renal failure in rats.

Authors:  Yanqing Tong; Bing Han; Hongyang Guo; Yanru Liu
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-07-03

2.  JYYS Granule Mitigates Renal Injury in Clinic and in Spontaneously Hypertensive Rats by Inhibiting NF-κB Signaling-Mediated Microinflammation.

Authors:  Dong Yan; Bowen Yue; Muyan Qian; Lili Zhao; Zihan Zhang; Hui Qian; Shihai Yan; Yuliang Qian; Zhuyuan Fang
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-26       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.